Newsletter Microbiota#5: Microbiome & Oncology

October 16, 2018




from Françoise Le Vacon, Chief Scientific Officer at Biofortis Mérieux NutriSciences.


Dear readers,


Cancer is a leading cause of morbidity and mortality worldwide, with the most common cancers occurring in lung, breast, and prostate.


Some chronic infections that particularly affect low and middle-income countries are risk factors for cancer. The main five behavioral and dietary risk factors are high body mass index, low fruit and vegetable consumption, lack of execerse, smoking and alcohol consumption. To fight cancer, many public and private organizations contribute to the lobal research effort. The latest findings on the possible role of the microbiome in some caner treatment responses appear promising. Thus, I am convinced that the microbiome field will offer new opportunities to develop patient stratification strategies and new adjuvant therapies that will improve the efficacy of anthineoplastic drugs or decrease their intestinal toxicity.


To better understand the contribution of the microbiota in cancer, ou Biofortis Mérieux NutriSciences teams are actively contributing to research efforts through different active collaborations with preclinical and clinical groups.


I would like to thank the patients who agree to participate in these clinical studies by giving samples and filling out some tedious questionnaires. 


I hope you will enjoy this new Biofortis Microbiota Newsletter dedicated to the microbiome and cancer.



Click here to request your biofortis newsletter

Share on Facebook
Share on Twitter
Share on LinkedIn
Share on Google+
Like this
Please reload


Please reload



  • LinkedIn Biofortis Mérieux NutriSc.
  • Twitter Biofortis Mérieux NutriSc.
  • YouTube Biofortis Mérieux NutriSc.


© 2017 Biofortis Mérieux NutriSciences


As part of Mérieux NutriSciences, Biofortis supports the food and health industries by conducting research projects with a unique nutrition and analytical service. A one-stop shop CRO offering innovative services including clinical assessments, microbiota-related research, sensory evaluation and consumer studies.


  • LinkedIn Biofortis Mérieux NutriSc.
  • Twitter Biofortis Mérieux NutriSc.
  • YouTube Biofortis Mérieux NutriSc.

3 Route de la Chatterie

44800 Saint-Herblain


Tel: +33 2 40 20 57 99